---
figid: PMC6266917__cancers-10-00408-g003
figlink: /pmc/articles/PMC6266917/figure/cancers-10-00408-f003/
number: F3
caption: Systemic effects of increased adiposity on EC progression. (a) A high level
  of circulating leptin binds to its receptor OB-R to trigger a signaling pathway
  as well as recruit pro-angiogenic factors such as VEGF, IL-1β, and LIF to induce
  cancer progression and metastasis. (b) Increased free fatty acids (FFA), resistin,
  and decreased adiponectin secretion contribute to insulin resistance, which leads
  to an increase in insulin synthesis. Hyperinsulinemia is associated with decreased
  bioavailability of IGFBP and the simultaneous increase in IGF-1 production. Insulin
  and IGF-1 signal through IR and IGFR respectively to promote EC progression via
  mTOR activation. (c) Hypertrophied adipocytes secrete an increasing amount of pro-inflammatory
  cytokines (IL-4, IL-7), ANGPT1, and VEGF to infiltrate endothelial cells, which
  facilitates angiogenesis. VEGF acts as a key mediator of the EC cell-adipocyte interaction
  and binds to its receptor, VEGFR2, on the EC cell surface. Phosphorylation of VEGFR2
  activates downstream targets and upregulates the mTOR pathway through a high pS6
  level.
pmcid: PMC6266917
papertitle: The Emerging Role of the Microenvironment in Endometrial Cancer.
reftext: Subhransu S. Sahoo, et al. Cancers (Basel). 2018 Nov;10(11):408.
pmc_ranked_result_index: '17287'
pathway_score: 0.9101012
filename: cancers-10-00408-g003.jpg
figtitle: Systemic effects of increased adiposity on EC progression
year: '2018'
organisms: Homo sapiens
ndex: bc313230-df11-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6266917__cancers-10-00408-g003.html
  '@type': Dataset
  description: Systemic effects of increased adiposity on EC progression. (a) A high
    level of circulating leptin binds to its receptor OB-R to trigger a signaling
    pathway as well as recruit pro-angiogenic factors such as VEGF, IL-1β, and LIF
    to induce cancer progression and metastasis. (b) Increased free fatty acids (FFA),
    resistin, and decreased adiponectin secretion contribute to insulin resistance,
    which leads to an increase in insulin synthesis. Hyperinsulinemia is associated
    with decreased bioavailability of IGFBP and the simultaneous increase in IGF-1
    production. Insulin and IGF-1 signal through IR and IGFR respectively to promote
    EC progression via mTOR activation. (c) Hypertrophied adipocytes secrete an increasing
    amount of pro-inflammatory cytokines (IL-4, IL-7), ANGPT1, and VEGF to infiltrate
    endothelial cells, which facilitates angiogenesis. VEGF acts as a key mediator
    of the EC cell-adipocyte interaction and binds to its receptor, VEGFR2, on the
    EC cell surface. Phosphorylation of VEGFR2 activates downstream targets and upregulates
    the mTOR pathway through a high pS6 level.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGFBP1
  - IGFBP7
  - IGFBP3
  - IGFBP5
  - KDR
  - ADIPOQ
  - IGFBP4
  - IGF1
  - IGFBP2
  - LEPR
  - PGF
  - VEGFD
  - VEGFA
  - IGFBP6
  - VEGFC
  - IGF1R
  - IL1B
  - IL1R1
  - AKT1
  - AKT2
  - ANGPT1
  - LIF
  - LIFR
  - AKT3
  - FLT1
  - FLT4
  - VEGFB
  - IL4
genes:
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP1
  entrez: '3484'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP7
  entrez: '3490'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP3
  entrez: '3486'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP5
  entrez: '3488'
- word: VEGFR2
  symbol: VEGFR2
  source: hgnc_alias_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: Adiponectin
  symbol: adiponectin
  source: hgnc_alias_symbol
  hgnc_symbol: ADIPOQ
  entrez: '9370'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP4
  entrez: '3487'
- word: IGF1
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP2
  entrez: '3485'
- word: OB-R
  symbol: OBR
  source: hgnc_alias_symbol
  hgnc_symbol: LEPR
  entrez: '3953'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP6
  entrez: '3489'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: IGFR
  symbol: IGFR
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: IL-1B
  symbol: IL-1B
  source: hgnc_alias_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: IL-1R
  symbol: IL1R
  source: hgnc_prev_symbol
  hgnc_symbol: IL1R1
  entrez: '3554'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: ANGPT1
  symbol: ANGPT1
  source: hgnc_symbol
  hgnc_symbol: ANGPT1
  entrez: '284'
- word: LIF
  symbol: LIF
  source: hgnc_symbol
  hgnc_symbol: LIF
  entrez: '3976'
- word: LIFR
  symbol: LIFR
  source: hgnc_symbol
  hgnc_symbol: LIFR
  entrez: '3977'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: IL-4
  symbol: IL-4
  source: hgnc_alias_symbol
  hgnc_symbol: IL4
  entrez: '3565'
- word: IL-4↑
  symbol: IL4
  source: hgnc_symbol
  hgnc_symbol: IL4
  entrez: '3565'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
chemicals: []
diseases: []
figid_alias: PMC6266917__F3
redirect_from: /figures/PMC6266917__F3
figtype: Figure
---
